The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to systematically characterize the gut microbiota of various critical chronic diseases, compare the similarities and differences of the microbiome signatures linked to different regions and diseases, and further investigate their impacts on microbiota-based diagnostic models.
Status: Recruiting Trial Number: NCT05638269
Conditions: Essential Hypertension,Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy Gastric Cancer Primary Aldosteronism Subclinical hypothyroïdism
Locations: 50 study locations throughout China. See link for full details.